Navigation Links
Max Neeman International Initiates Advisory Committee to Advance and Improve the Conduct of Complex Neurological Trials in India

RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2011 /PRNewswire/ -- India's premier CRO, Max Neeman, participated in the 59th annual Neurological Society of India & Congress of Neurological Surgeons (NEUROCON) held in Jaipur, India this past December.  The event was a convergence of leading neuroscientists, neurosurgeons, neurologists, physicians, surgeons, biotechnologists and researchers from across the globe to discuss advances made in the area of Neurology & Neurosurgery.


Max Neeman brought together USA and India based renowned group of Neuro and Spinal surgeons from prestigious hospitals across India and USA to form an advisory committee.

The Advisory Committee is to develop strategies for clinical research across newer therapies for central nervous system disorders.  Regulatory challenges and technical issues along with associated strategies of conducting the clinical trials of newer therapies in India were planned.

Max Neeman has conducted approximately 10% surgical intervention trials to date of over 230 trials awarded.  As part of the Max India Group, Max Neeman collaborates with 'Max Healthcare's' top physicians and neurosurgeons across India including Neurosciences departments, and one dedicated Neurological Institute, as part of the [8] hospital group; Max Healthcare.

About Max Neeman International

Max Neeman International is one of the leading and largest CROs in India and the clinical research arm of healthcare conglomerate, Max India.  Our specialty is that we offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company has 6 regional offices and 175 sites across 31 cities. Contact Donald Swankie, Vice President USA via email to or call +1.919.424.3345.

About Max Healthcare

Also part of the Max India group, Max Healthcare is part of a leading chain of hospitals in India.  Its state of the art infrastructure, top-notch physicians, and most advanced technologies makes it one of the best hospitals in the country.

SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Indias Favorable and Progressive Regulatory Environment Causes Accelerated Growth of Max Neeman Internationals Regulatory Services
2. Max Neeman International Signs Agreement for Data Management/EDC of Large Phase IV Trials from Multiple Sites
3. Max Neeman International to Open Phase I/IIa Unit
4. International Isotopes Inc. Announces a Shareholder Conference Call for February 7, 2011
5. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
6. 4th International Conference on Electrophoretic Deposition
7. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
8. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
9. Halt Medical Presents Strong Results of International Fibroid Studies at National Institutes of Health Global Congress
10. Web of international collaboration boosts worldwide nanotechnology research
11. ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program
Post Your Comments:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
Breaking Biology Technology:
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):